Research Article
Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI
Table 2
Lesion characteristics. Baseline size calculated as (T1 + T2)/2, size after therapy as (T3 + T4)/2. In four cases, the T4 measurement was not available and therefore the diameter measured at T3 used.
|